Vishal Venkatraman, Brittany G Futch, Alyssa Bartlett, Lexie Z Yang, Hui-Jie Lee, Ben Shofty, Beth A Parente, Shivanand P Lad, Theresa L Williamson, Shervin Rahimpour
BACKGROUND: Epilepsy affects 1% to 2% of the global population, and those who are resistant to medical treatment may be candidates for neuromodulation. In select populations, brain stimulation approaches including deep brain stimulation (DBS) and responsive neurostimulation (RNS) are used. Although studies have shown that patients from Black, Hispanic, lower income, and rural communities have less access to epilepsy care and have lower rates of epilepsy surgery, disparities in the use of brain stimulation for epilepsy treatment are currently not known...
December 28, 2023: Neuromodulation: Journal of the International Neuromodulation Society